Global Hearts is the flagship initiative of the World Health Organization to reduce the burden
of cardiovascular diseases, the leading cause of death and disability worldwide. HEARTS in …

Hypertension and diabetes are modifiable cardiovascular disease (CVD) risk factors that
contribute to nearly one-third of all deaths in the Americas Region each year (2.3 million …

ABSTRACT HEARTS in the Americas is the regional adaptation of the World Health
Organization's Global Hearts Initiative, which will be the model for risk management for …

ABSTRACT Objective. In 2021, Mexico launched the HEARTS program to improve the
prevention and control of cardiovascular disease (CVD) risk factors in 20 primary care …

HEARTS in the Americas, the regional adaptation of the WHO Global HEARTS Initiative, is
being implemented in 24 countries and over 2000 primary healthcare facilities across the …

Abstract The World Health Organization (WHO) Global Hearts Initiative offers technical
packages to reduce the burden of cardiovascular diseases through population‐wide and …

Hypertension is the leading risk factor for cardiovascular disease (CVD) worldwide. Despite
the availability of effective antihypertensive medications, the control of hypertension at a …

Globally, cardiovascular diseases (CVDs) are the leading cause of death. Viewed as a
threat to the global economy, the United Nations included reducing noncommunicable …

Cardiovascular disease (CVD) is the leading cause of illness burden in the Americas,
causing over 2 million deaths in 2017, a third of deaths overall for that year. While striking …

Despite numerous groundbreaking advances in the field, cardiovascular disease remains
the leading cause of mortality in the United States, accounting for more than 787,000 deaths …